Genmab — Juni 2017

[flottenschmecker]

EL - that is CASTOR, right?

[flottenschmecker]

Even with the lackluster performance of NICE, they must be able to evaluate a study of that magnitude within a year...

[flottenschmecker]

European commission approved CASTOR 2 months ago...

[E_L]

i think so. they dropped the submission with len/dex - https://www.nice.org.uk/guidance/indevelopment/gid-ta10104

[E_L]

and this is the one denied earlier in the year with final publication date july 20 https://www.nice.org.uk/guidance/indevelopment/gid-ta10076

[flottenschmecker]

well, if NICE rejects castor, then dara will not be available to Brits...

[flottenschmecker]

what kind of health authority will do that?

[flottenschmecker]

GEN har posted en opdateret investorpræsentation - http://files.shareholder.com/downloads/AMDA-KPIBN/4613191470x0x947487/A108DBB6-2E1C-4719-854E-A1D6D4DF853A/Kempen_April_2017.pdf

[flottenschmecker]

Den er godt nok fra april

[OHW]

Intet nyt fra NICE??

[E_L]

no nothing yet

[E_L]

Copenhagen, Denmark; June 27, 2017 — Genmab A/S (Nasdaq Copenhagen: GEN) will increase its share capital by 163,164 shares as a consequence of the exercise of employee warrants.

[E_L]

thought that would come in august... havent done my homework properly i guess
...

[E_L]

expains some of the selling pressure

[flottenschmecker]

We need the money to buy JnJ

[henrik48]

I går blev der her i gruppen talt om muligheden for at bruge Dara bredt mod al cancer..onkologer bruger i dag eksperimentelt denne behandlingsmåde med betegnelser som umbrella og basket-trials..dog ved jeg ikke om man bruger Dara..

[bibob]

Er det ikke AB eller Bankerne der presser kursen ned , ja så er det topcheferne selv. Virkelig dårlig timing.

[Solsen]

Gad vide om de sælger hele dynen ?

[JohnW]

Hvorfor tænker du det, Solsen?

[Solsen]

De er vel på vej til sommerferie